Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Cefditoren Pivoxil in Lactating Women
NCT06644105Phase 1Completed
- Sponsor
- West China Second University Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cefditoren in bacterial infection, sponsored by West China Second University Hospital. Primary endpoints: Relative Infant Dose at 12 hours and Milk-to-Plasma Ratio at 12 hours. Started Jan 2024; status: completed.
02
Drugs
cefditoren
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT06644105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06644105.